Elena Moro - Neurology

Author Information

Elena Moro is a prominent neurologist affiliated with the Movement Disorders Center, Division of Neurology at CHU Grenoble. She is also associated with the Grenoble Alpes University and INSERM U1214 in Grenoble, France. Her professional focus lies in the field of neurology, particularly in the study and treatment of movement disorders such as Parkinson's disease.

Research Contributions

Elena Moro has made significant contributions to the understanding and treatment of Parkinson's disease, as evidenced by her extensive research output. In 2022 alone, she has been involved in studies exploring various aspects of Parkinson's disease, including the safety and efficacy of adaptive deep brain stimulation, changes in the cholinergic system, and interventions to improve gait. Her work also touches upon the neuropsychiatric aspects of the disease, fatigue in de novo patients, and unmet needs of women living with Parkinson's disease. Her research is pivotal in advancing therapeutic approaches and identifying novel neuromodulation targets for effective treatment.

Aliases

Elena Moro is recognized in academic and research circles by various aliases, including E Moro and E. Moro. These variations are commonly used in her publications and professional interactions.

Publication and Citation Metrics

Metric	Value
Total Citations	17,139
H-index	68
Total Papers	314

Publications:

Double-blind cross-over pilot trial protocol to evaluate the safety and preliminary efficacy of long-term adaptive deep brain stimulation in patients with Parkinson’s disease

DOI: 10.1136/bmjopen-2021-049955

Year: 2022

Cholinergic system changes in Parkinson's disease: emerging therapeutic approaches

DOI: 10.1016/S1474-4422(21)00377-X

Year: 2022

Fatigue in de novo Parkinson's Disease: Expanding the Neuropsychiatric Triad?

DOI: 10.3233/jpd-213116

Year: 2022

Subtle anomaly detection: Application to brain MRI analysis of de novo Parkinsonian patients

DOI: 10.1016/j.artmed.2022.102251

Year: 2022

Short- and long-term outcome and predictors in an international cohort of patients with neuro COVID-19.

DOI: 10.1111/ene.15293

Year: 2022

Gaps and roadmap of novel neuromodulation targets for treatment of gait in Parkinson’s disease

DOI: 10.1038/s41531-021-00276-6

Year: 2022

Unmet Needs of Women Living with Parkinson's Disease: Gaps and Controversies

DOI: 10.1002/mds.28921

Year: 2022

Author Correction: Eight-hours conventional versus adaptive deep brain stimulation of the subthalamic nucleus in Parkinson’s disease

DOI: 10.1038/s41531-022-00281-3

Year: 2022

Effective connectivity in subcortical visual structures in de novo Patients with Parkinson’s Disease

DOI: 10.1016/j.nicl.2021.102906

Year: 2022

Interventions to improve gait in Parkinson’s disease: a systematic review of randomized controlled trials and network meta-analysis

DOI: 10.1007/s00415-022-11091-1

Year: 2022

What Are Lifestyle Modifications in Neurocare?

What is Epilepsy?

What Happens After Discharge?

What are the Components of Neurocare?

Are There Any Limitations to CBT?

What is the Role of Neurologists in Managing Insomnia?

How are Non-Motor Symptoms Diagnosed?

Can Lifestyle Changes Help?

What Are the Ethical Considerations?

What Causes Brain Tumors?

Partnered Content Networks

Relevant Topics